ANCA-associated vasculitis (AAV) may be a rare complication of exposure to COVID-19 proteins, either through infection or vaccination, a…
Articles by Margarida Maia, PhD
Immunoadsorption, a procedure that removes specific antibodies from the blood, may speed remission in patients with ANCA-associated vasculitis (AAV)…
Males are not at a greater risk than females of experiencing kidney failure or death due to ANCA-associated vasculitis…
Treatment with tofacitinib is well tolerated and effectively induces remission in people with ANCA-associated vasculitis (AAV), while enabling patients…
A first course of rituximab is sufficient to trigger the development of anti-rituximab antibodies in patients with systemic lupus…
Inflammatory vaginitis — inflammation of the vagina — may develop in women receiving long-term treatment with rituximab for ANCA-associated…
Mycophenolate mofetil (MMF) is well-tolerated and can be used to induce remission in people with eosinophilic granulomatosis with polyangiitis (EGPA),…
Rituximab is safe and effective for inducing remission in two types of ANCA-associated vasculitis in children and adolescents: granulomatosis…
A blood parameter called large unstained cell count or LUC – which measures the numbers of certain activated immune cells…
About one-third of patients with ANCA-associated vasculitis (AAV) or other forms of vasculitis postponed at least one of their…